How to Implement SOC in a Pharma Company — From Audit to 24/7 Monitoring

Why a pharma company needs SOC

NIS2 requires continuous cybersecurity monitoring. But for pharma, SOC is not just compliance — it is protection of drug production, clinical trial data, and supply chain. A pharmaceutical company without SOC is a company unaware of an ongoing attack until ransomware encrypts the production line. Average time to detect an attack without SOC: 207 days. With SOC: under 24 hours. Given the value of pharmaceutical data, this difference means millions of USD.

SOC specifics for pharma

OT monitoring alongside IT

A pharmaceutical SOC must monitor not only corporate networks but also production control systems (SCADA/DCS), LIMS/ELN systems, and environmental monitoring.

GMP context

SOC analysts must understand which systems are under GMP validation and how to escalate incidents affecting production data integrity.

Clinical data protection

Monitoring access to EDC systems, detecting research data exfiltration, alerting on investigator behavior anomalies.

Compliance-aware response

Response procedures accounting for reporting obligations: NIS2 (24h/72h), GDPR (72h), GMP (immediately to QA).

Internal SOC vs SOC as a Service

Internal SOC — full control, deep process knowledge. Cost: $500K-1.2M/year (team of 8-12, SIEM, tools). Justified for multinationals with multiple sites.

SOC as a Service — faster deployment (2-3 months), lower cost (from $4K/month), access to experts and threat intelligence. Ideal for mid-size pharma companies.

Hybrid model — internal L1/L2 for OT monitoring (requires production process knowledge), external L3 and threat hunting. Best option for large companies with manufacturing.

4-phase SOC implementation plan

Phase 1: Preparation (month 1-2)

• Inventory of systems to monitor (IT, OT, LIMS, EDC)
• Define pharma-specific use cases
• Select model (internal/external/hybrid)

Phase 2: Technical deployment (month 3-5)

• Deploy SIEM with log collectors
• Integrate sources: AD, firewalls, EDR, OT systems, LIMS
• Configure pharma-specific correlation rules

Phase 3: Operationalization (month 6-8)

• Rule tuning, false positive reduction
• Develop IR playbooks for pharma scenarios
• Integrate with GMP processes (QA notification)

Phase 4: Maturation (month 9-12)

• Proactive threat hunting
• Purple team exercises
• Metrics and reporting for management and regulators

Cybersecurity for Your Industry

Learn more about cybersecurity in your industry:

• Cybersecurity for Healthcare
• Cybersecurity for Pharma & Biotechnology

Best practices for implementation

Effective implementation requires several key steps:

1. Risk assessment and inventory — identify assets, threats, and vulnerabilities specific to your organization.
2. Policy development — document requirements, roles, and responsibilities.
3. Technical controls — deploy tools and configurations proportionate to identified risks.
4. Training and awareness — engage employees in protecting organizational security.
5. Monitoring and continuous improvement — regularly verify effectiveness and adapt to the evolving threat landscape.

Related topics

See also:

• NIS2 for hospitals — implementation and funding
• Security Audit Pricing Calculator
• NIS2 for hospitals — compliance